MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients.
about
The behavior of matrix metalloproteinases and their inhibitors in colorectal cancerMiR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells.Baicalein inhibits the migration and invasion of colorectal cancer cells via suppression of the AKT signaling pathway.MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer.Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients.Impact of proteolytic enzymes in colorectal cancer development and progression.Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.Associations of MMP-2 and MMP-9 gene polymorphism with ulinastatin efficacy in patients with severe acute pancreatitis.Unique insight into microenvironmental changes in colorectal cancer: Ex vivo assessment of matrix metalloprotease-mediated molecular changes in human colorectal tumor tissue and corresponding non-neoplastic adjacent tissue.Polymorphisms in matrix metalloproteinases 2, 3, and 8 increase recurrence and mortality risk by regulating enzyme activity in gastric adenocarcinoma.Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9.The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.Taiwanin E inhibits cell migration in human LoVo colon cancer cells by suppressing MMP-2/9 expression via p38 MAPK pathway.Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer.The inhibition of invasion of human melanoma cells through N-cadherin knock-down.Expression profile of NF-κB regulated genes in sporadic colorectal cancer patients.Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis
P2860
Q27004958-62267318-76F8-435B-AD98-2BBB586D8ED2Q36413914-AB73A459-3E80-43CC-A28F-D2BD22BD7199Q36502353-A47F99EB-3205-474A-9508-30B863C83594Q37230791-444CDDE1-5870-42B7-B7A1-43B8191F14F4Q37692836-3FC19623-2440-426D-B9AC-AA0DF36B76D6Q38259533-8365ED0C-CC4C-479E-BACF-3D7595CC0650Q38555225-44358E0D-ED3E-4035-96ED-A37E15CBAB4BQ41504736-CC7B1EA0-B8B0-40E4-914C-027D5AA5FFE7Q42143202-00281D48-588E-439A-8A54-2E22B8CF97D7Q47095977-C36BB99B-1E6F-498E-8FDE-4B4F8D738EC2Q47097061-A697E20F-321B-4E84-B1C5-61D38CFD800EQ51017220-066D86D2-6E5A-4F2C-B586-6D144ADA2888Q51155840-605A1DDD-A6DF-4525-A1BF-2C848C890AC4Q51347747-19BF69C8-2D37-4D0A-8C90-487221D09870Q54972156-98F5FDC2-1C98-4F1E-9C70-81D2126BB70AQ54982629-D86FB949-61A5-4C26-888F-4CF2FCE3BCABQ55412981-F676D64C-306C-45DC-A0C9-ECAE557D4781Q56530637-22156D33-668E-40B7-8637-733355F1E298
P2860
MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MMP-2 and MMP-9 in normal muco ...... of colorectal cancer patients.
@ast
MMP-2 and MMP-9 in normal muco ...... of colorectal cancer patients.
@en
type
label
MMP-2 and MMP-9 in normal muco ...... of colorectal cancer patients.
@ast
MMP-2 and MMP-9 in normal muco ...... of colorectal cancer patients.
@en
prefLabel
MMP-2 and MMP-9 in normal muco ...... of colorectal cancer patients.
@ast
MMP-2 and MMP-9 in normal muco ...... of colorectal cancer patients.
@en
P2093
P2860
P50
P356
P1476
MMP-2 and MMP-9 in normal muco ...... of colorectal cancer patients
@en
P2093
A M J Langers
D W Hommes
F J G M Kubben
H W Verspaget
J J van der Reijden
W van Duijn
P2860
P2888
P304
P356
10.1038/BJC.2012.80
P407
P577
2012-04-01T00:00:00Z